Orchard Therapeutics plc
Orchard Therapeutics plc (ORTX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ORTX · as of Jun 9, 2026
Key Statistics
Explore Orchard Therapeutics plc Data
ortx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 10 · Buy rate: 60.0%
Competitors & Peers
ortx competitorsORTX
CKPT
CLYM
CTEV
GTHX
ITOSStock Performance
Full HistoryAbout Orchard Therapeutics plc
Orchard Therapeutics plc is a biopharmaceutical firm dedicated to developing gene-based treatments for severe and often fatal rare conditions, operating across the United Kingdom, European Union, and …
what is orchard therapeutics plc · ortx stock overview · orchard therapeutics plc company profile · who is orchard therapeutics plc ceo · ortx NASDAQ · orchard therapeutics plc headquarters · orchard therapeutics plc business segments
About Stock Overview & Key Data
Orchard Therapeutics plc (ORTX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 31, 2018. As of the latest trading session, ORTX stock price is $16.70, with a market capitalization of $380.1M. The stock has returned +203.64% over the past 12 months and +1.71% year-to-date.
According to 10 Wall Street analysts, the consensus rating for Orchard Therapeutics plc stock is Buy, with an average 12-month price target of $—. In fiscal year 2022, Orchard Therapeutics plc reported revenue of $7.0M and net income of -$7.9M. For detailed data — including Orchard Therapeutics plc revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Orchard Therapeutics plc (ORTX) stock price is $16.70. The stock is traded on NASDAQ under the ticker symbol ORTX. The 52-week range is $4.24 – $16.72.